Corona Remedies (NSE:CORONA) Construction In Progress: ₹1,467 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CORONA Corona Remedies Ltd NSE:CORONA
18 GF Score
Price ₹2,098.80
! 3 Warning Signs
View Full Analysis

What is Corona Remedies Construction In Progress?

Corona Remedies NSE:CORONA +0.37% 18 Construction In Progress is ₹1,467 Mil as of Mar. 2026. GuruFocus rates NSE:CORONA with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Corona Remedies's quarterly construction in progress declined from Jun. 2025 (₹2,027 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,467 Mil).

Corona Remedies's annual construction in progress increased from Mar. 2024 (₹1,280 Mil) to Mar. 2025 (₹1,938 Mil) but then declined from Mar. 2025 (₹1,938 Mil) to Mar. 2026 (₹1,467 Mil).

Corona Remedies Construction In Progress Historical Data

* Premium members only.

The historical data trend for Corona Remedies's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corona Remedies Construction In Progress Chart

Corona Remedies Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Construction In Progress
733.53 1,279.89 1,938.30 1,466.90

Corona Remedies Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial 0.00 1,938.30 2,027.33 0.00 1,466.90
NSE:CORONA
18GF Score
Corona Remedies Ltd NSE:CORONA
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corona Remedies Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹1,467 Mil mean?
Corona Remedies (NSE:CORONA) has a Construction In Progress of ₹1,467 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Corona Remedies and its competitors.
Is Corona Remedies' Construction In Progress too high?
Corona Remedies' current Construction In Progress is ₹1,467 Mil. Overall, Corona Remedies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Corona Remedies' Construction In Progress compare to LLY and JNJ?
Corona Remedies' Construction In Progress of ₹1,467 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Corona Remedies and its competitors. Corona Remedies's current Construction In Progress is ₹1,467 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corona Remedies stock overvalued right now?
Corona Remedies (NSE:CORONA) has a current Construction In Progress of ₹1,467 Mil. The current Construction In Progress is ₹1,467 Mil. Corona Remedies' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Corona Remedies (NSE:CORONA), the current Construction In Progress is ₹1,467 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corona Remedies Business Description

Other Exchanges 544644:India
Address S. G. Highway, CORONA House, C - Mondeal Business Park, Near Gurudwara, Thaltej, Ahmedabad, GJ, IND, 380 059
Corona Remedies Ltd is mainly engaged in the business of manufacturing, trading and marketing of Pharmaceutical products. It is engaged in developing, manufacturing and marketing products in women's healthcare, cardio-diabetes, pain management, urology and other segments, such as Vitamin Minerals and Nutrients(VMN), gastrointestinal and respiratory therapies. The company's brands are B-29, myoril, Tricium, Cortel, and Obimet. The Company has only one reportable business segment i.e. Pharmaceuticals. The company has presence in India as well as Outside India. The company generates majority of revenue from India.
18GF Score

Get the complete analysis for NSE:CORONA

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,098.80
Price